DE69636228D1 - Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen - Google Patents
Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis InfektionenInfo
- Publication number
- DE69636228D1 DE69636228D1 DE69636228T DE69636228T DE69636228D1 DE 69636228 D1 DE69636228 D1 DE 69636228D1 DE 69636228 T DE69636228 T DE 69636228T DE 69636228 T DE69636228 T DE 69636228T DE 69636228 D1 DE69636228 D1 DE 69636228D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- lawsonia intracellularis
- therapeutic compositions
- intracellularis infections
- prophylaxis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001148567 Lawsonia intracellularis Species 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN6911A AUPN691195A0 (en) | 1995-11-30 | 1995-11-30 | Therapeutic and diagnostic compositions - B |
| AUPN6910A AUPN691095A0 (en) | 1995-11-30 | 1995-11-30 | Therapeutic and diagnostic compositions - A |
| PCT/AU1996/000767 WO1997020050A1 (en) | 1995-11-30 | 1996-11-29 | Therapeutic and diagnostic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69636228D1 true DE69636228D1 (de) | 2006-07-20 |
Family
ID=25645072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69636228T Expired - Lifetime DE69636228D1 (de) | 1995-11-30 | 1996-11-29 | Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7022328B1 (de) |
| EP (1) | EP0871735B1 (de) |
| JP (1) | JP2000502054A (de) |
| CN (1) | CN1145697C (de) |
| AT (1) | ATE329031T1 (de) |
| AU (1) | AU718333B2 (de) |
| BR (1) | BR9611623A (de) |
| CA (1) | CA2236574A1 (de) |
| DE (1) | DE69636228D1 (de) |
| NZ (1) | NZ322398A (de) |
| WO (1) | WO1997020050A1 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2345061A (en) * | 1998-12-21 | 2000-06-28 | Secr Defence | Protein and nucleic acid sequences of groES and groEL from B.pseudomallei and their use as a vaccine |
| JP2003501013A (ja) * | 1999-05-13 | 2003-01-14 | ファイザー プロダクツ インコーポレーティッド | ローソニア由来の遺伝子及び関連ＳｏｄＣポリペプチド、ぺプチド及びタンパク質並びにそれらの使用 |
| WO2000069906A1 (en) * | 1999-05-13 | 2000-11-23 | Pfizer Products Inc | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| AU771376B2 (en) * | 1999-05-13 | 2004-03-18 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses |
| US7052697B1 (en) * | 1999-05-13 | 2006-05-30 | Agriculture Victoria Services Pty Ltd | Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| WO2000069905A1 (en) * | 1999-05-13 | 2000-11-23 | Australian Pork Limited | LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| US7029683B1 (en) | 1999-05-13 | 2006-04-18 | Pfizer Products, Inc. | Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses |
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| EP1094070A3 (de) * | 1999-10-22 | 2002-01-09 | Pfizer Products Inc. | Lawsonia intracellularis Proteine sowie Methoden und Materialien die diese verwenden |
| GB0021757D0 (en) * | 2000-09-04 | 2000-10-18 | Colaco Camilo | Vaccine against microbial pathogens |
| JP2004529854A (ja) * | 2000-09-29 | 2004-09-30 | アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ | 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法 |
| EP1332154A4 (de) * | 2000-11-10 | 2005-05-11 | Agriculture Victoria Serv Pty | Therapeutische zusammensetzung zur behandlung einer lawsonia ssp infektion(21.05.02) |
| DK1219711T3 (da) | 2000-12-20 | 2006-09-25 | Intervet Int Bv | Lawsonia Intracellularis vaccine |
| MY146476A (en) | 2004-06-24 | 2012-08-15 | Boehringer Ingelheim Vetmed | Method of diagnosing lawsonia intracellularis |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| TW200716166A (en) * | 2005-04-28 | 2007-05-01 | Boehringer Ingelheim Vetmed | Lawsonia intracellularis immunological proteins |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| US20080241190A1 (en) * | 2006-11-13 | 2008-10-02 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of horses against lawsonia intracellularis |
| EP2101815A4 (de) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | Wirksames verfahren zur behandlung von infektionen mit porcinem circovirus und lawsonia intracellularis |
| EP2200643B1 (de) | 2007-09-17 | 2013-09-04 | Boehringer Ingelheim Vetmedica, Inc. | Ein lawsonia intracellularis lebendimpfstoff verabreicht in kombination mit einem antibiotikum zur behandlung von lawsonia intracellularis infektionen in schweine |
| TWI449533B (zh) | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| TWI551295B (zh) * | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| UA100047C2 (ru) * | 2008-04-18 | 2012-11-12 | Интервет Интернешонал Б.В. | Вакцина для защиты от lawsonia intracellularis |
| EP2318041B1 (de) * | 2008-07-22 | 2015-02-25 | Intervet International BV | Lawsonia intracellularis bakterium eines neuartigen serotyps, impfstoff auf der basis dieses bakteriums, zur diagnose des neuartigen lawsonia intracellularis serotyps geeignete antikörper und hybridome zur erzeugung dieser antikörper |
| US8142760B2 (en) * | 2008-09-05 | 2012-03-27 | Nathan Len Winkelman | Vaccination for Lawsonia intracellularis |
| DK3076996T3 (en) | 2013-12-03 | 2020-03-09 | Intervet Int Bv | Vaccine mod porcint circovirus type 2 |
| ES2695172T3 (es) * | 2013-12-03 | 2019-01-02 | Intervet Int Bv | Vacuna porcina contra SRRP y Lawsonia intracellularis |
| EP3076995B1 (de) | 2013-12-03 | 2020-03-11 | Intervet International B.V. | Impfstoff gegen lawsonia intracellularis und porcine circovirus typ 2 |
| WO2016124620A1 (en) | 2015-02-04 | 2016-08-11 | Intervet International B.V. | A vaccine for use against subclinical lawsonia infection in a pig |
| JP2018504423A (ja) | 2015-02-04 | 2018-02-15 | インターベット インターナショナル ベー． フェー． | 豚における無症候性ローソニア感染症に対する使用のためのワクチン |
| KR20200127003A (ko) * | 2018-02-28 | 2020-11-09 | 베링거잉겔하임베트메디카게엠베하 | 동물에서 스카톨 및/또는 인돌을 감소시키는 방법 |
| AU2022375120A1 (en) | 2021-11-01 | 2024-04-11 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic gel compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610059A (en) | 1992-11-09 | 1997-03-11 | University Of Arizona | Etiological agent for porcine enteritis |
| WO1995014093A1 (en) * | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| US5714375A (en) * | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US6379677B1 (en) * | 2000-02-25 | 2002-04-30 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Streptococcus iniae vaccine |
-
1996
- 1996-11-29 JP JP9520010A patent/JP2000502054A/ja not_active Ceased
- 1996-11-29 AT AT96938863T patent/ATE329031T1/de not_active IP Right Cessation
- 1996-11-29 AU AU76141/96A patent/AU718333B2/en not_active Ceased
- 1996-11-29 NZ NZ322398A patent/NZ322398A/en unknown
- 1996-11-29 EP EP96938863A patent/EP0871735B1/de not_active Expired - Lifetime
- 1996-11-29 US US09/077,574 patent/US7022328B1/en not_active Expired - Fee Related
- 1996-11-29 DE DE69636228T patent/DE69636228D1/de not_active Expired - Lifetime
- 1996-11-29 CN CNB961986662A patent/CN1145697C/zh not_active Expired - Fee Related
- 1996-11-29 WO PCT/AU1996/000767 patent/WO1997020050A1/en active IP Right Grant
- 1996-11-29 CA CA002236574A patent/CA2236574A1/en not_active Abandoned
- 1996-11-29 BR BR9611623-4A patent/BR9611623A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ322398A (en) | 2000-02-28 |
| WO1997020050A1 (en) | 1997-06-05 |
| EP0871735A1 (de) | 1998-10-21 |
| AU718333B2 (en) | 2000-04-13 |
| JP2000502054A (ja) | 2000-02-22 |
| EP0871735A4 (de) | 2001-12-05 |
| CA2236574A1 (en) | 1997-06-05 |
| ATE329031T1 (de) | 2006-06-15 |
| CN1145697C (zh) | 2004-04-14 |
| EP0871735B1 (de) | 2006-06-07 |
| BR9611623A (pt) | 1999-12-28 |
| US7022328B1 (en) | 2006-04-04 |
| AU7614196A (en) | 1997-06-19 |
| CN1203630A (zh) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69636228D1 (de) | Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen | |
| ATE154935T1 (de) | Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit | |
| ATE218880T1 (de) | Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum | |
| NO20030316D0 (no) | Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker | |
| ATE510562T1 (de) | Anti-ailim antikörper zur behandlung von crohn's | |
| DE60325945D1 (de) | Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen | |
| DE69934010D1 (de) | Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten | |
| YU46097A (sh) | Nova klasa estara i njihove farmaceutske smeše | |
| ATE310391T1 (de) | Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen | |
| BR0015698A (pt) | Composições e métodos para tratamento de doenças alérgicas | |
| ATE289821T1 (de) | Verfahren zur behandlung einer diarrhöischen krankheit und zur eliminierung besonderer bakterieller populationen im dickdarm | |
| BR0200571A (pt) | Produtos de legumes | |
| ATE408618T1 (de) | Synthetische peptidkonstrukte zur erkennung und behandlung von parodontose hervorgerufen durch porphyromonas gingivalis | |
| ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| ATE110960T1 (de) | Bakterielle mittel zur verwendung bei geflügel. | |
| SE8903625L (sv) | Antibacterial composition | |
| EA200001029A1 (ru) | Производные гигромицина | |
| HUP0003845A2 (hu) | Antimikrobiális 8a-azalidok alkalmazása | |
| DE69829995D1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen | |
| DE69918826D1 (de) | Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen | |
| ATE212229T1 (de) | Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden | |
| DE60041266D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| DE69619542T2 (de) | Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden | |
| Arnold et al. | Influence of Diarrhea upon Gastro-Intestinal Auto-Disinfection. | |
| ATE211914T1 (de) | Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |